ELPEN is a privately owned, Greek pharmaceutical company with operations worldwide. Established in 1965, the group currently has 900 employees and an annual turnover of €200 million. It ranks as 1st among Greek companies and 7th overall among 400 companies operating in Greece. At the moment, its products are commercialized in 39 countries and all of them are manufactured under the strict EU guidelines. ELPEN has a production facility of 10.000m2 and its research facility (The Experimental – Research Center ELPEN) is the first and largest laboratory for experimental biomedical research and training center in Greece that originates from the private sector and it is ranked within the top 5 in Europe. If you are interested in learning more about the rich pipeline of products that ELPEN is working on, please contact our International Business Development team.